Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Dec 30:5:51.
doi: 10.1186/1476-7120-5-51.

The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease

Ahmet Yildiz  1 , M Akif Cakar, Murat Baskurt, Baris Okcun, Deniz Guzelsoy, Ugur Coskun
Affiliations

The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease

Ahmet Yildiz et al. Cardiovasc Ultrasound. .

Abstract

Background: Statins improve the endothelial function in patients with coronary artery disease (CAD). However, they contribute to the substantial decrease in coronary heart disease by reducing plasma cholesterol levels. They also, reduce oxidative stress, stabilize the atherosclerotic plaque and inhibit inflammatory response. These functions of statins have been briefly described as pleiotropic effects. The aim of our study was to evaluate the effect of atorvastatin therapy on endothelial functions in patients with CAD.

Methods: Fourty-nine patients (40 men, 9 women, mean age 59 +/- 11 years) with diagnosed CAD were selected as the study group. The patients were given 10 mg/day atorvastatin for 12 weeks. If the target cholesterol levels has not been achieved 6 weeks after the treatment, then the daily atorvastatin dosage has been increased. The endothelial function was evaluated by flow mediated dilatation (FMD) of the brachial artery.

Results: It has been figured out that 12 weeks later, atorvastatin caused a statistically significant decrease in the plasma levels of LDL-cholesterol and total cholesterol (p < 0,0001). Meanwhile, it was determined that the FMD got statistically significant improved 12 weeks after the atorvastatin therapy (8,1%-4,2%, p < 0,001). However there was no statistically significant change in non-endothelium dependent dilatation (NID).

Conclusion: Endothelium derived vasodilatation (EBD), which was non-invasively detected via brachial artery ultrasonography, had statistically significant improvment within 12 weeks of atorvastatin therapy whereas non-endothelium dependent dilatation (NID) had no change.

PubMed Disclaimer

References

    1. Rossouw JE, Lewis B, Rifkind BM. The value of lowering cholesterol after myocardial infarction. N Engl J Med. 323:1112–9. 1990 Oct 18. - PubMed
    1. Vita JA, Keaney JF., Jr Hormone replacement therapy and endothelial function: the exception that proves the rule? Arterioscler Thromb Vasc Biol. 2001;21:1867–1869. - PubMed
    1. West of Scotland Coronary Prevention study group Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention study (WOSCOPS) Circulation. 97:1440–1445. 1998 Apr 21. - PubMed
    1. Smith GD, Shipley MJ, Marmot MG, Rose G. Plasma cholesterol concentration and mortality. The Whitehall Study. J Am Med Assoc. 267:70–6. doi: 10.1001/jama.267.1.70. 1992 Jan 1. - DOI - PubMed
    1. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 26:1235–1241. doi: 10.1016/0735-1097(95)00327-4. 1995 Nov 1. - DOI - PubMed

LinkOut - more resources